Florida, March 05, 2018:

    Blood Screening Market 2018 to 2021

    The Blood Screening Market is expected to exceed more than US$ 2.00 Billion by 2021 at a CAGR of 9% in the given forecast period.

    The scope of the report includes a detailed study of global and regional markets on Blood Screening Market with the reasons given for variations in the growth of the industry in certain regions.

    The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market.

    Key players profiled in the report are as below:

     Ortho Clinical Diagnostics, Inc

    Becton, Grifols

    Dickinson and Company  

    Roche Diagnostics

    Beckman Coulter, Inc

    Abbott Laboratories

    Thermo Fisher Scientific, Inc

    Bio-Rad Laboratories

    and Siemens Healthineers

    bioMérieux

    Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

    You Can Browse Full Report: https://www.marketresearchengine.com/blood-screening-market

    The Blood Screening Market has been segmented as below : (Accordingly)

    By Technology Analysis:

    • Nucleic Acid Test (NAT)
      • Transcription-mediated Amplification (TMA)
      • Real-time Polymerase Chain Reaction (PCR)
    • Enzyme-linked Immunosorbent Assay (ELISA)
      • By Platform
        • Chemiluminescence Immunoassay (CLIA)
        • Fluorescence Immunoassay (FIA)
        • Colorimetric Immunoassay (CI)
      • By Generation
        • First Generation
        • Second Generation
        • Third Generation
        • Fourth Generation & Above
    • Rapid Tests
    • Western Blot Assay
    • Next-generation Sequencing (NGS)

    By End User Analysis:

    • Blood Banks
    • Hospitals

    By Product/Services Analysis:

    • Reagents & Kits
      • NAT Reagents & Kits
    • Enzymes and Polymerases
    • Standards and Controls
    • Probes and Primers
    • Buffers, Nucleotides, and Solutions
    • Labeling and Detection Reagents
      • ELISA Reagents & Kits
    • Immunosorbents
    • Controls
    • Conjugates
    • Substrates
    • Sample Diluents and Wash Solutions
      • Other Reagents & Kits
    • Instruments
      • Rental Purchase
      • Outright Purchase
    • Software and Services

    By Regional Analysis

    North America
    Europe
    Asia-Pacific
    Rest of the World

    This report provides:

    1) An overview of the global market for Blood Screening Market and related technologies.
    2) Analyses of global market trends, with data from 2015, estimates for 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2025.
    3) Identifications of new market opportunities and targeted promotional plans for Blood Screening Market.
    4) Discussion of research and development, and the demand for new products and new applications.
    5) Comprehensive company profiles of major players in the industry.

    Buy Report from here: https://www.marketresearchengine.com/blood-screening-market

    Table of Contents

    1    INTRODUCTION
        1.1    KEY TAKE AWAYS
    1.2    REPORT DESCRIPTION
    1.3    MARKETS COVERED
    1.4    STAKEHOLDERS
    1.5    RESEARCH METHODOLOGY
    1.5.1    MARKET SIZE
    1.5.2    MARKET SHARE
    1.5.3    KEY DATA POINTS FROM SECONDARY SOURCES
    1.5.4    KEY DATA POINTS FROM PRIMARY SOURCES

    2 Research Methodology 
    2.1 Secondary Data
    2.1.1 Key Data From Secondary Sources
    2.2 Primary Data
    2.2.1 Key Data From Primary Sources
    2.3 Market Size Estimation
    2.3.1 Bottom-Up Approach
    2.3.2 Top-Down Approach
    2.4 Market Breakdown & Data Triangulation
    2.5 Assumptions for the Study

    3 Executive Summary
        3.1 Introduction
    3.2 Current Scenario
    3.3 Conclusion

    4 Premium Insights 
    4.1 Blood Screening Market
    4.2 Blood Screening Market, By Region & Technology

    5 Market Overview 
    5.1 Introduction
    5.2 Market Dynamics
    5.2.1 Drivers
    5.2.1.1 Increasing Number of Blood Donations and Blood Donors
    5.2.1.2 Increasing Demand of Donated Blood
    5.2.1.3 Rising Prevalence of Infectious Diseases
    5.2.1.4 Growing Affordability and Adoption of NAT for Blood Screening
    5.2.1.5 Rising Awareness Regarding the Safety of Donated Blood
    5.2.2 Restraints
    5.2.2.1 Capital Expenditure and Operating Costs of NAT
    5.2.2.2 Lack of Regulations Mandating the Use of NAT in Developing Countries
    5.2.2.3 Emergence of Alternative Technologies
    5.2.3 Opportunities
    5.2.3.1 Pathogen Reduction Technology
    5.2.3.2 Multiplex Tests
    5.2.3.3 Emerging Economies
    5.2.4 Challenges
    5.2.4.1 Price Reduction

    6 Blood Screening Market, By Technology 
    6.1 Introduction
    6.2 Blood Screening Market, By Volume (Number of Tests Conducted)
    6.3 Nucleic Acid Test (NAT)
    6.3.1 Transcription-Mediated Amplification (TMA)
    6.3.2 Real-Time Polymerase Chain Reaction (PCR)
    6.4 Enzyme-Linked Immunosorbent Assay (ELISA)
    6.4.1 ELISA Market, By Platform
    6.4.1.1 Chemiluminescence Immunoassay (CLIA)
    6.4.1.2 Fluorescence Immunoassay (FIA)
    6.4.1.3 Colorimetric Immunoassay (CI)
    6.4.2 ELISA Market, By Generation
    6.4.2.1 First-Generation ELISA
    6.4.2.2 Second-Generation ELISA
    6.4.2.3 Third-Generation ELISA
    6.4.2.4 Fourth-Generation & Above
    6.5 Rapid Tests
    6.6 Western Blot Assay
    6.7 Next-Generation Sequencing (NGS)

    7 Blood Screening Market, By Product and Service
        7.1 Introduction
    7.2 Reagents & Kits
    7.2.1 NAT Reagents & Kits
    7.2.1.1 Enzymes and Polymerases
    7.2.1.2 Standards and Controls
    7.2.1.3 Probes and Primers
    7.2.1.4 Buffers, Nucleotides and Solutions
    7.2.1.5 Labeling and Detection Reagents
    7.2.2 ELISA Reagents & Kits
    7.2.2.1 Immunosorbents
    7.2.2.2 Controls
    7.2.2.3 Conjugates (Antigen Or Antibody-Conjugated Enzyme)
    7.2.2.4 Substrates (Of Enzymes)
    7.2.2.5 Sample Diluents and Wash Solutions
    7.2.3 Other Reagents
    7.3 Instruments
    7.3.1 Rental Purchase
    7.3.2 Outright Purchase
    7.4 Software and Services

    8 Blood Screening Market, By End User
        8.1 Introduction
    8.2 Blood Banks
    8.3 Hospitals

    9 Blood Screening Market, By Region
        9.1 Introduction
    9.2 North America
    9.2.1 U.S.
    9.2.2 Canada
    9.3 Europe
    9.3.1 Germany
    9.3.2 France
    9.3.3 U.K.
    9.3.4 Italy
    9.3.5 Spain
    9.3.6 Rest of Europe (RoE)
    9.4 Asia
    9.4.1 Japan
    9.4.2 China
    9.4.3 India
    9.4.4 Rest of Asia (RoA)
    9.5 Rest of the World (RoW)

    10 Competitive Landscape
         10.1 Overview
    10.2 Market Share Analysis
    10.2.1 Market Share Analysis for NAT
    10.2.2 Blood Screening Market Share Analysis
    10.3 Competitive Situations and Trends
    10.3.1 Product Launches
    10.3.2 Regulatory Approvals
    10.3.3 Agreements
    10.3.4 Partnerships
    10.3.5 Acquisitions
    10.3.6 Expansions

    11 Company Profiles
         11.1 Introduction
    11.2 Grifols
    11.3 F. Hoffmann-La Roche
    11.4 Abbott Laboratories
    11.5 Biomérieux
    11.6 Bio-Rad Laboratories, Inc.
    11.7 Siemens Healthineers (A Subsidiary of Siemens AG)
    11.8 Ortho Clinical Diagnostics, Inc.
    11.9 Thermo Fisher Scientific, Inc.
    11.10 Beckman Coulter (A Subsidiary of Danaher Corporation)
    11.11 Becton, Dickinson and Company

    Media Contact

    Company Name: Market Research Engine

    Contact Person: John Bay

    Email: john@marketresearchengine.com

    Phone: +1-855-984-1862

    Country: United States

    Website: https://www.marketresearchengine.com/

     

    Source: http://www.financeswire.com/blood-screening-market-share-2018-industry-analysis-growth-and-forecast-to-2021